ChronSeal: Phase I/II data

In a Norwegian and Swedish Phase I/II trial in about 40 patients, 10 and 50 ng/mL topical ChronSeal for 1 week significantly reduced mean wound size by 34% and 30%, respectively, vs. a 6% increase for...